This story has been updated from a previous version to include comments from Quidel's earnings call.

NEW YORK (GenomeWeb) –  Quidel reported after the close of the market on Wednesday that its second quarter revenues dropped 2 percent year over year, driven by a decline in influenza-related testing.

For the three months ended June 30, the company reported that revenues dropped to $38.3 million from $39.1 million in Q2 2016, and missed the average analysts' estimate of $41.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.